Intermittent versus continuous systemic therapy as treatment for unresectable metastatic colorectal cancer
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To assess the effect of intermittent systemic therapy versus continuous systemic therapy in terms of survival, toxicity and quality of life in patients with unresectable metastatic colorectal cancer (CRC).